Dallas Testosterone Therapy Injury Attorneys

Dallas Testosterone Therapy Injury attorneys at L|T Legal Team, are investigating cases of patients who have suffered heart attacks or strokes while using testosterone therapies. Testosterone treatments can lead to an increased risk of heart attacks and strokes. That is the results from two recent scientific studies, one of which was published in the Journal of the American Medical Association. Testosterone therapy increases the for heart attacks, strokes, and even death by 30%. These findings from independent studies contradict the pharmaceutical industry studies that claim testosterone therapy does not increase the risk of cardiovascular injuries related to testosterone therapies.

The pharmaceutical attorneys at L|T Legal Team are actively investigating claims of men that have suffered heart attacks, strokes or death while using testosterone therapy. If you or a loved one believes you may have a claim, call us today at 214-484-1930 to discuss your rights. With over 20 years of combined experience taking on pharmaceutical companies, our pharmaceutical lawyers are the right choice for you.

Testosterone Therapy Risks Outweigh the Benefits

The increased risk of heart attack and stroke from testosterone therapy is especially frightening considering the large numbers of men that have been prescribed this therapy. In 2011, over 5.3 million testosterone therapy prescriptions were written to men totaling $1.6 billion in sales. Like many bad drugs in the past, such as Vioxx and Bextra, aggressive direct to customer marketing campaigns have played a large role in the increase of testosterone therapy. Testosterone therapy is generally prescribed to aging men diagnosed with low testosterone. The benefits of the therapy include increased sex drive, bone density, increased muscle mass and strength. The new studies, however, casts serious doubts on whether these benefits are greatly outweighed by the increased risk of heart attack or stroke. The news of these risks have led the FDA to begin its own new investigation into the link between testosterone therapy and heart attacks, strokes, and death. The warning issued by the FDA can be found here.

The Studies

Links to the studies that discovered the increased risk of heart attack, stroke, and death can be found here and here. Essentially, the studies were observational studies that looked at he affects of testosterone therapy over a large sample of men. The studies noted a marked increase in heart attack, stroke, and death in men above 65 that had no prior history of cardiovascular disease. For men under the age of 65, the noted increase in heart attacks, stroke, and death were only seen in men with prior cardiovascular disease. These studies have led the FDA to “reassess the safety issues” surrounding testosterone therapy.

What Hormone Therapies Are We Investigating?

While the FDA continues its own investigation into the negative affects of testosterone therapy, we are actively representing those patients who suffered heart attacks, strokes, and deaths while using the following testosterone treatments:

• AndroGel: this is a concentrated quick-drying gel that is applied to the skin made by Abbott Labs and AbbVie Labs.

• AndroDerm: A testosterone patch made by Actavis, Inc. (formerly Watson Pharmaceuticals) that delivers testosterone through skin on the back, abdomen, thighs, or arms.

• Axiron: A topical solution to treat low-t made by Eli Lilly and applied to the armpits.

• Bio-T Gel: A once-daily testosterone treatment gel made by GlaxoSmithKline.

• Delatestryl: A testosterone injection treatment created by Savient Pharmaceuticals that is injected into the buttock muscle every 1 to 4 weeks.

• Depo-Testosterone: Introduced by Pfizer in 2003, this is an intramuscular agent for low testosterone (low-t) and available in two strengths, 100 mg/mL and 200 mg/mL testosterone cypionate.

• Foresta: A testosterone spray gel that is applied to front and inner thighs daily. Foresta is made by Endo Pharmaceuticals and approved in December 2010 as a Class III product for topical use for men with low testosterone. Endo warns that “Safety and efficacy of Foresta Gel in males less than 18 years old have not been established.” Endo also warns that its product “can transfer from your body to others… Women and children should avoid contact with the unwashed or unclothed areas where Foresta Gel has been applied.”

• Striant (generic: testosterone buccal system): A tablet made by Columbia laboratories, Inc. and later purchased by Auxilium Pharmaceuticals containing 30 mg of slowly released testosterone.

• Testim: A gel testosterone treatment made by Auxilium that users apply to the shoulders.

• Testopel: A Slate Pharmaceuticals testosterone implant that is placed under the skin and releases the hormone over a period of 3 to 6 months.

If you or a loved one has taken any of these testosterone treatments and have suffered a heart attack, stroke, or death, call us today so that we can start protecting your rights.